These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 18538090)

  • 21. L-Tyrosine Confers Residualizing Properties to a d-Amino Acid-Rich Residualizing Peptide for Radioiodination of Internalizing Antibodies.
    Lee FT; Burvenich IJ; Guo N; Kocovski P; Tochon-Danguy H; Ackermann U; O'Keefe GJ; Gong S; Rigopoulos A; Liu Z; Gan HK; Scott AM
    Mol Imaging; 2016; 15():. PubMed ID: 27457521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Biodegradation of 125I-labeled monoclonal antibodies after introvenous administration to rats with experimental C6 glioma].
    Chekhonina VP; Bulanov KA; Iusubalieva GM; Tsibul'kina EA; Gurina OI; Skoblov IuA; Shvets VI; Zhirkv IuA; Baklaushev VP
    Biomed Khim; 2007; 53(5):532-40. PubMed ID: 18078067
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preclinical evaluation of [¹¹¹ In]-DOTA-trastuzumab for clinical trials.
    Alirezapour B; Jalilian AR; Rajabifar S; Mirzaii M; Moradkhani S; Pouladi M; Aslani G
    J Cancer Res Ther; 2014; 10(1):112-20. PubMed ID: 24762497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In-vitro internalization and in-vivo tumor uptake of anti-EGFR monoclonal antibody LA22 in A549 lung cancer cells and animal model.
    Liu Z; Yu Z; He W; Ma S; Sun L; Wang F
    Cancer Biother Radiopharm; 2009 Feb; 24(1):15-24. PubMed ID: 19216631
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preclinical antilymphoma activity of a humanized anti-CD40 monoclonal antibody, SGN-40.
    Law CL; Gordon KA; Collier J; Klussman K; McEarchern JA; Cerveny CG; Mixan BJ; Lee WP; Lin Z; Valdez P; Wahl AF; Grewal IS
    Cancer Res; 2005 Sep; 65(18):8331-8. PubMed ID: 16166310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reagents for astatination of biomolecules. 2. Conjugation of anionic boron cage pendant groups to a protein provides a method for direct labeling that is stable to in vivo deastatination.
    Wilbur DS; Chyan MK; Hamlin DK; Vessella RL; Wedge TJ; Hawthorne MF
    Bioconjug Chem; 2007; 18(4):1226-40. PubMed ID: 17583925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro and in vivo targeting properties of iodine-123- or iodine-131-labeled monoclonal antibody 14C5 in a non-small cell lung cancer and colon carcinoma model.
    Burvenich I; Schoonooghe S; Cornelissen B; Blanckaert P; Coene E; Cuvelier C; Mertens N; Slegers G
    Clin Cancer Res; 2005 Oct; 11(20):7288-96. PubMed ID: 16243799
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methods for radiolabelling of monoclonal antibodies.
    Tolmachev V; Orlova A; Andersson K
    Methods Mol Biol; 2014; 1060():309-30. PubMed ID: 24037848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiolabeled humanized anti-CD3 monoclonal antibody visilizumab for imaging human T-lymphocytes.
    Malviya G; D'Alessandria C; Bonanno E; Vexler V; Massari R; Trotta C; Scopinaro F; Dierckx R; Signore A
    J Nucl Med; 2009 Oct; 50(10):1683-91. PubMed ID: 19759100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High yield direct 76Br-bromination of monoclonal antibodies using chloramine-T.
    Sundin J; Tolmachev V; Koziorowski J; Carlsson J; Lundqvist H; Welt S; Larson S; Sundin A
    Nucl Med Biol; 1999 Nov; 26(8):923-9. PubMed ID: 10708306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Feasibility of iodine-125 labeled anti-human hemoglobin antibody in the detection of bleeding sites from the large bowel-A preliminary study.
    Prado GL; Abe Y; Saito H; Nakamura K
    Tohoku J Exp Med; 2001 Jul; 194(3):141-6. PubMed ID: 11693662
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PET with the 89Zr-labeled transforming growth factor-β antibody fresolimumab in tumor models.
    Oude Munnink TH; Arjaans ME; Timmer-Bosscha H; Schröder CP; Hesselink JW; Vedelaar SR; Walenkamp AM; Reiss M; Gregory RC; Lub-de Hooge MN; de Vries EG
    J Nucl Med; 2011 Dec; 52(12):2001-8. PubMed ID: 22072706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumour targeting of the anti-ovarian carcinoma x anti-CD3/TCR bispesific monoclonal antibody OC/TR and its parental MOv18 antibody in experimental ovarian cancer.
    Boerman OC; Tibben JG; Massuger LF; Claessens RA; Corstens FH
    Anticancer Res; 1995; 15(5B):2169-74. PubMed ID: 8572619
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiobromination of humanized anti-HER2 monoclonal antibody trastuzumab using N-succinimidyl 5-bromo-3-pyridinecarboxylate, a potential label for immunoPET.
    Mume E; Orlova A; Malmström PU; Lundqvist H; Sjöberg S; Tolmachev V
    Nucl Med Biol; 2005 Aug; 32(6):613-22. PubMed ID: 16026708
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of DOTA and NODAGA as chelators for (64)Cu-labeled immunoconjugates.
    Ghosh SC; Pinkston KL; Robinson H; Harvey BR; Wilganowski N; Gore K; Sevick-Muraca EM; Azhdarinia A
    Nucl Med Biol; 2015 Feb; 42(2):177-83. PubMed ID: 25457653
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiepidermal growth factor variant III scFv fragment: effect of radioiodination method on tumor targeting and normal tissue clearance.
    Shankar S; Vaidyanathan G; Kuan CT; Bigner DD; Zalutsky MR
    Nucl Med Biol; 2006 Jan; 33(1):101-10. PubMed ID: 16459265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Method for radioiodination of proteins using N-succinimidyl 3-hydroxy-4-iodobenzoate.
    Vaidyanathan G; Affleck DJ; Zalutsky MR
    Bioconjug Chem; 1997; 8(5):724-9. PubMed ID: 9327137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radio-iodination of monoclonal antibody using potassium [125I]-(4-isothiocyanatobenzylammonio)-iodo-decahydro-closo-dodecaborate (iodo-DABI).
    Orlova A; Bruskin A; Sivaev I; Sjöberg S; Lundqvist H; Tolmachev V
    Anticancer Res; 2006; 26(2A):1217-23. PubMed ID: 16619527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of [⁶⁴Cu]-DOTA-PR81 radioimmunoconjugate for MUC-1 positive PET imaging.
    Alirezapour B; Rasaee MJ; Jalilian AR; Rajabifar S; Mohammadnejad J; Paknejad M; Maadi E; Moradkhani S
    Nucl Med Biol; 2016 Jan; 43(1):73-80. PubMed ID: 26453525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluating the potential of 188Re-SOCTA-trastuzumab as a new radioimmunoagent for breast cancer treatment.
    Luo TY; Tang IC; Wu YL; Hsu KL; Liu SW; Kung HC; Lai PS; Lin WJ
    Nucl Med Biol; 2009 Jan; 36(1):81-8. PubMed ID: 19181272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.